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Prostate cancer is one of the most common cancers among men and has long been recognized to occur in familial
clusters. Brothers and sons of affected men have a 2–3-fold increased risk of developing prostate cancer. However,
identiﬁcation of genetic susceptibility loci for prostate cancer has been extremely difﬁcult. Although the suggestion
of linkage has been reported for many chromosomes, the most promising regions have been difﬁcult to replicate.
In this study, we compare genome linkage scans using microsatellites with those using single-nucleotide polymor-
phisms (SNPs), performed in 467 men with prostate cancer from 167 families. For the microsatellites, the ABI
Prism Linkage Mapping Set version 2, with 402 microsatellite markers, was used, and, for the SNPs, the Early
Access Affymetrix Mapping 10K array was used. Our results show that the presence of linkage disequilibrium (LD)
among SNPs can lead to inﬂated LOD scores, and this seems to be an artifact due to the assumption of linkage
equilibrium that is required by the current genetic-linkage software. After excluding SNPs with high LD, we found
a number of new LOD-score peaks with values of at least 2.0 that were not found by the microsatellite markers:
chromosome 8, with a maximum model-free LOD score of 2.2; chromosome 2, with a LOD score of 2.1; chro-
mosome 6, with a LOD score of 4.2; and chromosome 12, with a LOD score of 3.9. The LOD scores for
chromosomes 6 and 12 are difﬁcult to interpret, because they occurred only at the extreme ends of the chromosomes.
The greatest gain provided by the SNP markers was a large increase in the linkage information content, with an
average information content of 61% for the SNPs, versus an average of 41% for the microsatellite markers. The
strengths and weaknesses of microsatellite versus SNP markers are illustrated by the results of our genome linkage
scans.
Introduction
Prostate cancer (MIM 176807) is one of the most com-
mon cancers in men in the Western world, as well as a
leading cause of mortality, yet little is known about its
causes. Old age, African American ancestry, and a family
history of prostate cancer have long been recognized as
important risk factors, yet we are only at the early stage
of unraveling the complex genetic and environmental
inﬂuences on this disease. Over the past 20 years, the
body of evidence that genetics plays a key role has grown
immensely, including a range of studies—from familial
aggregation and twin studies, to family-based linkage
studies, to detection of likely functional genes via mu-
tation screening, to molecular epidemiological studies of
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both rare and common polymorphisms of candidate
genes (Schaid 2004). However, the evidence also points
toward a much more complex genetic basis of prostate
cancer than was initially anticipated. Early linkage re-
sults have provided targeted candidate regions for pros-
tate cancer–susceptibility loci, including HPC1 (MIM
601518) on chromosome 1q23-25 (Smith et al. 1996;
Xu and International Consortium for Prostate Cancer
Genetics 2000; Carpten et al. 2002), PCAP (MIM
602759) on chromosome 1q42-43 (Berthon et al. 1998),
CAPB (MIM 603688) on chromosome 1p36 (Gibbs et
al. 1999), chromosome 8p22-23 (Xu et al. 2001),HPC2
(MIM 605367) on chromosome 17p (Tavtigian et al.
2001), HPC20 (MIM 608656) on chromosome 20q13
(Berry et al. 2000), and HPCX (MIM 300146) on chro-
mosome Xq27-28 (Xu et al. 1998). However, further
reports and 10 genome linkage screens based on micro-
satellite markers (for reviews, see Easton et al. [2003]
and Schaid [2004]) have demonstrated the difﬁculty in
replicating linkage ﬁndings for prostate cancer suscep-
tibility. Some causes of this complexity are likely to be
a high rate of phenocopies; a lack of complete genetic
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information, because parents and older ancestors of men
with prostate cancer are not available to genotype; low
to moderate penetrance of susceptibility genes; multiple
genes; and a variety of heterogeneous environmental risk
factors.
One way to enrich genetic linkage information is to
increase the marker density. Like many other groups
using microsatellite markers, we have used the ABI
Prism Linkage Mapping Set (Applied Biosystems) of
STRs that have an average spacing of 10 cM. In con-
trast, the Early Access Affymetrix Mapping 10K array,
which contains ∼10,000 SNP markers, is estimated to
have an average spacing of 0.34 cM. To avoid confusion
between the abbreviations STR and SNP, we will here-
after use the abbreviation “M-STR” for microsatellite
marker. An advantage of the M-STRs is that they are
highly polymorphic, much more so than the diallelic
SNPs. The advantage of the SNPs is that they are much
more plentiful, and the hope is that their greater density
will compensate for the smaller amount of information
per SNP, by creating local haplotypes of SNPs that func-
tion as “super” alleles, which, jointly as a haplotype,
have greater linkage information content. There has
been considerable debate on the advantages and dis-
advantages of M-STRs versus SNPs, in terms of their
relative linkage information content, the ability of soft-
ware to analyze the large number of SNPs, and the effect
of linkage disequilibrium (LD) among the SNPs (current
software for analyzing a large number of markers as-
sumes that the markers are in linkage equilibrium). The
present study has two objectives. The ﬁrst aim is to
perform a dense linkage analysis of the families with
prostate cancer in our study, to extract nearly the max-
imum linkage information content. The second aim is
to summarize our experience with using both M-STRs
and SNPs on a common set of pedigrees, to assist in
the scientiﬁc evaluation of the strengths and weaknesses
of both genomic technologies.
Methods
Selection of Families
Each family was selected through a proband who re-
ceived treatment for prostate cancer at the Mayo Clinic,
with the requirement of at least three men with prostate
cancer in the family, of whom at least two were alive
for recruitment. The details of our large-scale survey,
telephone follow-up, and family recruitment can be
found elsewhere (Schaid et al. 1998; Cunningham et al.
2003). For the genotyping of M-STRs, we used 160 fam-
ilies, which included 437 men affected with prostate can-
cer and 157 unaffected men and women. For the ge-
notyping of SNPs, we used 433 of these affected men
from 159 families (four men were excluded because of
degraded DNA, and one family was excluded, because
it was no longer informative, as a result of degraded
DNA). Because of cost constraints, we did not genotype
the SNPs for the unaffected members of these original
families. In addition, nine new affected subjects have
been added to these pedigrees, and eight new pedigrees
were recruited (25 affected men and 17 unaffected men
and women). Hence, for the SNPs, all affected men in
the original pedigrees were genotyped, and all members
of the new pedigrees were genotyped, resulting in 167
families with 467 affected men. For the comparisons of
linkage results from M-STRs versus SNPs, we used only
the 159 families with 433 affected men that were ge-
notyped by both technologies.
The research protocol and informed consents were ap-
proved by the Mayo Clinic Institutional Review Board.
DNA was isolated from peripheral blood lymphocytes by
standard methods.
Genetic Markers and Genotyping
For the M-STRs, the ABI Prism Linkage Mapping Set
version 2 (Applied Biosystems), with 402 markers, was
used as described by Cunningham et al. (2003). For the
SNPs, the Early Access Affymetrix Mapping 10K array
was used in accordance with the manufacturer’s rec-
ommendations. In brief, 250 ng of high-quality genomic
DNA was digested with XbaI (20,000 U/ml), and adap-
tor sequences were ligated using T4 ligase on the digested
DNA. After PCR ampliﬁcation with Xba primers (250
mM dNTPs, 2.5 mM MgCl2, 0.75 mM each primer, and
0.1 U of AmpliTaq Gold), amplicons were processed via
MinElute plate with a QIAvac 96 vacuum manifold and
were quantiﬁed; 20 mg was required for the subsequent
steps of fragmentation with DNase I, end labeling with
biotinylated ddATP, and hybridization to the 10K array.
Hybridization was detected by streptavidin-phycoeryth-
rin conjugates. Arrays were processed through an Af-
fymetrix microﬂuidics station and then were scanned on
an Agilent reader. Quality controls included check gel
electrophoresis after the PCR (2% agarose) and frag-
mentation (4% agarose) steps. Robotic workstations
were used whenever possible, to minimize the chance of
specimen-handling errors.
Statistical Analyses
Genetic Maps
The chromosome genetic maps for the M-STRs are
based on the CEPH data and the Genethon linkage map
(Gyapay et al. 1994). The average intermarker distance
is 9.4 cM (25th–75th percentiles 7.1–11.3 cM). Because
these maps were based on many more informative mei-
oses than were available in our pedigrees, the maps were
assumed to be correct. The chromosome genetic maps
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Table 1
Characteristics of the 167 Families Used in Linkage Analysis
FAMILIES
NO. OF
FAMILIES
AVERAGE NO. OF
AFFECTED INDIVIDUALS
PER FAMILY (range)
AVERAGE AGE AT DIAGNOSIS
IN FAMILIES (SD)
(years)
AFFECTED INDIVIDUALS WITH
DNA AVAILABLE
No. of
Individuals
Average per
Family (Range)
All 167 4.5 (3–11) 65.5 (5.0) 467 2.8 (2–7)
With average age at diagnosis:
!66 years 84 4.6 (3–10) 61.7 (3.7) 230 2.7 (2–5)
66 years 83 4.5 (3–11) 69.5 (2.2) 237 2.9 (2–7)
With no. of affected men:
!5 100 3.4 (3–4) 65.4 (5.3) 241 2.4 (2–4)
5 67 6.2 (5–11) 65.7 (4.4) 226 3.4 (2–7)
With paternal transmission:
Yes 80 4.9 (3–10) 65.1 (5.3) 217 2.7 (2–5)
No 87 4.2 (3–11) 66.0 (4.6) 250 2.9 (2–7)
With HPC:
Yes 129 4.7 (3–11) 65.8 (5.2) 365 2.8 (2–7)
No 38 3.9 (3–8) 64.6 (4.0) 102 2.7 (2–5)
of the SNPs were created by Affymetrix, by (1) placing
the deCODEmicrosatellites (Kong et al. 2002) and SNPs
on the physical sequence map, (2) using the deCODE
microsatellite map as a framework, and (3) using linear
interpolation to place the SNPs on inferred geneticmaps.
Because the SNP genetic maps were not based onmeioses
within families, we used our families with prostate can-
cer to perform a crude validity check (crude, because
our families are not very informative for construction
and validation of ﬁne-scale genetic-marker maps). To
perform this check, we used the software CRIMAP
(Lander and Green 1987) with the “ﬂips2” option. This
procedure ﬂips adjacent marker loci along the assumed
genetic-map sequence and reports LOD scores for the
original sequence versus the ﬂipped sequence. If the LOD
score favored the ﬂipped sequence by a LOD score of
at least 1.0, then the order of the two markers involved
was considered suspicious, and so the marker with the
least heterozygosity was excluded from further analyses.
LOD-Score Calculations
The frequencies of all marker alleles, both M-STRs
and SNPs, were estimated across the pool of all subjects,
ignoring genetic relationships. Because founders of our
pedigrees were not available to genotype, allele fre-
quencies of the marker alleles can have a large impact
on our linkage results. To avoid potential bias caused
by rare alleles, we present analyses based only on SNPs
with minor-allele frequencies of at least 5%. Multipoint
model-free analyses based on the Kong and Cox (1997)
exponential model were conducted by the softwareMer-
lin (Abecasis et al. 2002). Although we attempted to
analyze the SNP data by use of Genehunter Plus, a mod-
iﬁed version of Genehunter version 1.3 (Kruglyak et al.
1996), this software was limited by the large number of
SNPs on some chromosomes. The information content
of the genotypes was estimated by Merlin, by use of the
entropy information described by Kruglyak et al. (1996).
Results
Families and Affected Men
The 167 families used for our genome linkage screen
are described in table 1. There was one family with His-
panic heritage, one with African American heritage, and
the remaining with white heritage. The average age at
diagnosis per family ranged from 47 years to 75 years,
with 21 families having an average age at diagnosis !60
years. The number of affected men per family ranged
from 3 to 11, and the number of affected men with DNA
available ranged from 2 to 7. To classify pedigrees as
having hereditary prostate cancer (HPC) or not, we used
the Carter criteria (Carter et al. 1993), which require a
pedigree to have at least one of the following three cri-
teria to be classiﬁed as a pedigree with HPC: (1) three
consecutive generations of prostate cancer along a line
of descent, (2) at least three ﬁrst-degree relatives with a
diagnosis of prostate cancer, or (3) two or more relatives
with a prostate cancer diagnosis at an age 55 years.
Although 77% of our families were classiﬁed as having
HPC, only 40% had ﬁve or more men with prostate
cancer, 48% had both a father and a son with prostate
cancer (“paternal transmission”), and 50% had an av-
erage age at diagnosis !66 years. Seventy-ﬁve families
had two affected men whose DNA was available, 62
families had three, 22 families had four; and 8 families
had ﬁve or more.
Among the 467 affected men with available DNA,
prostate cancer was conﬁrmed by review of medical rec-
ords for all but two men. A majority of men (90%)
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Table 2
Reduction from 10,043 SNPs in the Affymetrix Early-Access Chip
to 5,656 SNPs Used in Analyses
Reason Excluded (in Sequential Order) No. Excluded
Excluded from production chipa 1,096
Missing genetic-map positionb 484
Call rate per SNP !90% 849
Conﬂicting map positionsc 4
Low informationd 778
Questionable chromosome ordere 8
Failed HWE, P ! .001 7
Mendelian errors in multiple pedigrees 3
High LD with neighboring SNPsf 1,158
a Reasons for exclusion include unacceptable call rates, poor
cluster scores, reproduction problems, Mendelian errors, visually
unacceptable SNPs, SNPs in the same physical position, Hardy-
Weinberg disequilibrium, chromosome-X heterozygotes, cross-
hybridization, and discordance between SNP calls and single base
extension.
b Map position was determined by linear interpolation of physical
sequence onto deCODE genetic map and was supplied by Affym-
etrix, but genetic-map position or chromosome number was missing
at the time of analysis.
c Genetic-map position fromAffymetrix for early-access (EA) chip
and production (P) chip differed: SNP 52738 (EA on chromosome
3, P on chromosome 14); SNP 55401 (EA on chromosome 5, P on
chromosome 12); SNP 1511280 (EA on chromosome 3, P on chro-
mosome 16); and SNP 1525228 (EA on chromosome 7, P on chro-
mosome 11). The chromosome location of the production chip of
two of these four SNPs were questionable (SNPs 52738 and
1511280 were far outside the map lengths of chromosomes reported
by deCODE), so all four SNPs were excluded.
d 119 SNPs were not polymorphic; 130 SNPs had only 1–4 total
copies of the rare allele (allele frequency !0.5%); 529 SNPs had a
minor allele frequency 0.5%–4.9%.
e Chromosome order of SNPs evaluated by CRIMAP multipoint
with the “ﬂips2” option gave a LOD score of 1.0 that favored the
ﬂipped order, compared with the order provided by Affymetrix.
f For each cluster of SNPs with allele frequencies at least 5%,
pairwise 10.7 for any two SNPs in a cluster was used to indicate′FDF
excessive LD; only the most informative (highest heterozygosity)
SNP from each cluster was used in linkage analyses, and all other
SNPs with high LD were excluded.
received diagnoses through a clinically indicated biopsy,
and a majority (68%) received diagnoses after 1990,
when prostate-speciﬁc antigen (PSA) screening became
more widely used. Although most men had a PSA level
4 at the time of diagnosis, PSA at diagnosis was miss-
ing for 24% of the men, and 10% had PSA levels !4.
Gleason grade tended to be low for the group of men,
with 58% having Gleason grade !7, and 18% with a
missing grade. Most men did not have nodal involve-
ment or metastatic prostate cancer at the time of diag-
nosis (82%). In addition, most men (66%) had a BMI
!28 (BMI computed as the height [cm] squared, divided
by weight [kg]). The most common type of treatment
was radical prostatectomy alone (69%), followed by ex-
ternal-beam radiation therapy alone (16%).
Genotype Quality
The quality of the M-STR genotype data was checked
in numerous ways, including Mendelian inheritance
checks, checks for departures from Hardy-Weinberg ge-
notype proportions, range checks on allele sizes, and
veriﬁcation of extremely rare alleles (for a summary of
the quality of microsatellite genotype data, see Cun-
ningham et al. 2003). Questionable genotypes were set
to missing. After cleaning the M-STR data, we had 96%
of the genotypes expected if there were no missing data.
Reported relationships were evaluated by the software
Relpair (Boehnke and Cox 1997), and subjects with
questionable relationships were excluded from analyses.
Note that the M-STR analyses were completed before
initiation of SNP genotyping, and subjects with ques-
tionable relationships were never genotyped for the
SNPs. This results in potentially fewer erroneous rela-
tionships than those detected by SNPs alone.
For the Early Access Affymetrix Mapping 10K array,
there were 10,043 SNPs available for analysis. Because
some of the SNPs on the early-access array were replaced
in the Affymetrix ﬁnal production array for various rea-
sons (see reasons stated in the table 2 footnotes), we
took a conservative approach by analyzing only those
SNPs that were included in the ﬁnal production chip
(1,096 SNPs were excluded). For each SNP, the call rate
(percentage of successful genotype calls among subjects)
was used as a measure of quality, and we excluded SNPs
with call rates !90% (849 excluded). Mendelian inher-
itance was evaluated, although, of the 167 pedigrees in
our study, only 6 were capable of showing Mendelian-
inheritance errors for diallelic SNPs, if errors existed.
Three SNPs were excluded as a result of Mendelian in-
consistencies in multiple pedigrees. To test for Hardy-
Weinberg equilibrium (HWE), one subject from each
pedigree was randomly sampled, an exact test for HWE
was performed, and this process was repeated 100 times,
to compute an average P value per SNP. This simulation
process avoids using related subjects in the test for HWE
but uses an average over a large number of random
samples to be sure that conclusions are not based on an
unusual random sample. Seven SNPs were excluded as
a result of departure from HWE. After the above-men-
tioned data cleaning, additional genotypes that were
likely erroneous, as determined by the default error-de-
tection option of Merlin (Abecasis et al. 2002), were
removed. A summary of the reasons for excluding SNPs
from analyses are listed in sequential order in table 2.
For the SNP analysis, a total of 510 Affymetrix Map-
ping 10K arrays were processed (467 affected males, 9
unaffected males, 9 females, 11 internal controls, and
14 repeats), resulting in 15 million genotypes. Through-
out the project, quality was assessed by monitoring a
number of parameters. These included monitoring the
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Figure 1 Distribution of pairwise values according to the pairwise distance of SNPs within 5 cM (top panel). The solid horizontal′FDF
line in the top panel is the threshold for high LD at . The distribution of the high-LD SNPs is given in the lower left panel, and the′FDF 1 0.7
distribution of the pairwise distances between the high-LD SNPs is given in the lower right panel.
overall call rate per array (i.e., over all SNPs for a sub-
ject), the overall call rate per SNP (i.e., over all subjects
for a SNP), the heterozygosity frequency per array, and,
for SNPs on the X chromosome, checking for hetero-
zygotes. The mean call rate per array was 0.95, with a
range of 0.81–0.97. All arrays that had a call rate !0.90
were retested ( ), and all retests resulted in callnp 14
rates 10.89. The mean call rate per SNP across all sub-
jects was 0.95 (range 0.006–1.0), with 2,829 SNPs hav-
ing a call rate of 1.00. For the 5,656 SNPs used in the
ﬁnal analyses (see table 2), the mean call rate per SNP
was 0.99 (range 0.90–1.0), with 1,912 SNPs having a
call rate of 1.00. For all men in this study, it was possible
to examine markers on the X chromosome for errors
due to miscalls or PCR contamination (i.e., heterozy-
gotes should not be observed). No SNPs were hetero-
zygous for males. Finally, to estimate the genotyping
error rate, ﬁve samples were tested multiple times. For
the pairwise comparisons of replicate samples, 157 ge-
notype discrepancies were found, giving an estimated
error rate of 0.08%. Overall, the quality of results was
excellent, with a very low error rate.
Impact of LD on Linkage Results
Current software available to compute multipoint
linkage analyses for a large number of genetic markers
assumes that the markers are in linkage equilibrium.
Although this may be reasonable for the widely spaced
M-STR markers, LD is likely to exist among some of
the closely spaced SNPs. To evaluate the impact of LD
on our linkage results, we performed analyses both with
and without the SNPs in high LD, restricted to SNPs
with minor-allele frequencies of at least 5%. To identify
high-LD SNPs, we computed the pairwise LD measure
between each SNP and all other SNPs within 5-cM′FD F
distance from it. Because linkage phase of the SNPs is
not directly observed, we simpliﬁed our approach by
ignoring relationships among family members and by
using the expectation-maximization algorithm (Excof-
ﬁer and Slatkin 1995) to estimate 2-locus haplotype fre-
quencies, fromwhich could be calculated. Although′FD F
ignoring relationships may result in a loss of efﬁciency,
it should not introduce bias into our estimates. Figure
1 (top panel) illustrates the distribution of accord-′FD F
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Table 3
Location of Maximum LOD Scores 12.0 and Flanking M-STR Markers
CHROMOSOME
MAXIMUM LOD
SCORE
SNP POSITION
(cM)
M-STR
Upstream Downstream
2 2.1 242.48 D2S2205 D2S2973
6 4.2 183.26 D6S297 D6S1697
8 2.2 54.91 D8S1750 D8S571
12 3.9 169.62 D12S1723 D12S357
20 2.4 75.81 D20S436 D20S897
X 2.2 161.05 DXS8073 DXS8045
ing to the pairwise distance of SNPs within 5 cM. We
used a threshold of to deﬁne the high-LD′FD F 1 0.7
SNPs, and their distribution (ﬁg. 1, lower left panel)
illustrates that the majority of the high-LD SNPs had
, and the distribution of pairwise distances′FD Fp 1.0
between the high-LD SNPs (ﬁg. 1, lower right panel)
illustrates that the majority of high-LD SNPswerewithin
0.5 cM of each other (median distance 0.16 cM; 25th–
75th percentiles 0.01–0.55 cM). Among the clusters of
SNPs that had , only one SNP (the most in-′FD F 1 0.7
formative) from each cluster was used in the linkage
analyses. A total of 1,158 SNPs were excluded, because
they were in strong LD with remaining SNPs.
The LOD scores for the analyses with and without
the high-LD SNPs are illustrated in ﬁgure 2. The panels
of this ﬁgure illustrate that the high-LD SNPs can lead
to inﬂated LOD scores. In some cases, the inﬂated LOD
scores were extreme, such as for chromosomes 4, 6, and
14. The tick marks along the bottom panels of ﬁgure 2
illustrate where the SNPs of high LD were excluded. The
information contents for the analyses in ﬁgure 2 were
nearly identical, with a mean of 0.65 when the high-LD
SNPs were included versus a mean of 0.63 when the
high-LD SNPs were excluded. Plots of information con-
tent per chromosome (not shown) illustrated that ex-
clusion of the high-LD SNPs had little impact on the
information content. We interpret these ﬁndings to mean
that the presence of LD among SNPs artiﬁcially increases
the LOD scores. All results in ﬁgure 2 excluded SNPs
with minor-allele frequencies !5%. Because we were cu-
rious about the impact of rare alleles, we reanalyzed our
genome scan, including SNPs with rare alleles, for the
analyses that included high-LD SNPs. The resulting
LOD scores were indistinguishable from those presented
in ﬁgure 2, for which the high-LD SNPs were included
(data not shown). Hence, it appears that the high-LD
SNPs had the greatest impact on the LOD scores, rather
than the allele frequencies. All these analyses are based
on removal of likely genotype errors, determined by the
error-detection option of Merlin. A total of 1,391 ge-
notypes were declared likely to be erroneous by Merlin,
resulting in a genotype error rate of 0.05%, which is
close to the rate of 0.08% estimated in our replicate
samples. To evaluate the impact of this genotype elim-
ination, we ran the analyses, after removing the high-
LD SNPs, both before and after removing the likely ge-
notype errors. The difference in maximum LOD scores
(after vs. before) ranged from 0.42 to 0.08 across the
chromosomes. Because genotyping errors were difﬁcult
to detect with SNPs and because their presence can
falsely deﬂate LOD scores (Douglas et al. 2000; Sobel
et al. 2002), all subsequent results are based on removal
of likely errors by Merlin’s algorithm.
Because some of the high-LD SNPs had a large impact
on the linkage ﬁndings, we excluded the high-LD SNPs
from further analyses. For the remaining 5,656 SNPs
used in the linkage analyses, the average inter-SNP dis-
tance was 0.63 cM (25th–75th percentile 0.06–0.77
cM). The chromosomes that had LOD scores of at least
2 were chromosomes 2, 8, 12, 20, and X. The solid lines
in ﬁgure 2 show where these maximum values occurred,
and table 3 gives numeric LOD scores and ﬂanking M-
STR markers. The results for chromosome 20 are con-
sistent with the linkage results we reported elsewhere for
M-STR markers (Berry et al. 2000), which are further
evaluated below. The results for chromosome 8 are con-
sistent with the linkage ﬁndings of Xu et al. (2001), and
the results for chromosome X are consistent with our
prior analyses with M-STRs (Xu et al. 1998). The link-
age ﬁndings for chromosomes 2, 6, and 12 are a bit odd,
given that the maximum LOD scores occurred at the
extreme ends of the chromosomes. Further genotyping
at the ends of these chromosomes may help validate
these ﬁndings.
SNP versus M-STR LOD Scores
After excluding the high-LD SNPs, we compared the
linkage ﬁndings from three types of genetic marker data:
(1) M-STRs alone, (2) SNPs alone, and (3) the combi-
nation of M-STRs and SNPs. For these comparisons, we
used only those subjects who had genotypes available
for both genotyping technologies. The LOD scores from
these three types of genetic marker data are presented
in ﬁgure 3, along with their information content. For
many regions of the chromosomes, the LOD-score
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curves for SNPs, M-STRs, and the combination of both
were fairly similar, although it was not unusual to ﬁnd
a number of slightly higher peaks for the SNPs, com-
pared with the M-STRs (e.g., see ﬁg. 3, chromosome 1).
For a number of chromosomes, the LOD-score peak was
dramatically higher for the SNP markers (either alone
or combined with M-STRs) than for the M-STRs alone
(e.g., see ﬁg. 3, chromosomes 2–8, 12, 14, and 16). The
unusual aspect of some of these differences is the narrow
width of the LOD-score peaks for the SNPs (see ﬁg. 3,
chromosome 4). We speculate that these narrow peaks
could be caused by several factors, including the fact
that the high density of the SNPs could provide more
narrow peaks than the M-STR markers and that un-
accounted LD could bias the LOD scores for SNPs to
be spuriously high. The only place where the SNPs had
a much lower LOD score than the M-STR markers was
on the X chromosome, at !50 cM, where the SNPs were
less informative than the M-STRs.
On the basis of only M-STR markers, we have re-
ported positive linkage to chromosome 20 (Cunningham
et al. 2003). It is interesting to note that the SNPmarkers
tend to reﬁne the region of the maximum LOD score
(ﬁg. 3). For the M-STR markers, the maximum LOD
score was 2.96 at 66.1 cM, and the width of the 1-LOD
region of support was 29.3 cM. For the SNPs, there were
two peaks separated by 53 cM: themaximumLOD score
at 22.5 cM was 2.16 (width of 1-LOD support 15.8
cM), and the maximum LOD score at 75.7 cM was 2.85
(width of 1-LOD support 19.8 cM). These results sug-
gest that there may be two susceptibility loci on chro-
mosome 20. Hence, the SNPs provided greater linkage
resolution for chromosome 20 than M-STRs alone. It is
also interesting that the M-STR markers do not con-
tribute additional information to that already provided
by the SNPs.
The contrast of information content in ﬁgure 3 illus-
trates that the SNPs provided much more linkage infor-
mation than the M-STRs, despite the lower information
content per SNP, compared with that per M-STR. Over
all chromosome positions, the average information for
the M-STRs was 41% (SD 7.5%); for the SNPs, 61%
(SD 6.1%); and for the combination of bothM-STRs and
SNPs, 64% (SD 4.7%). To provide a more complete
global view of the information content of the three types
of genetic marker data, we computed the percentage of
the genome that had information content above a range
of thresholds. The genome percentage was computed by
determining the length of the genome that exceeded an
information threshold, divided by the total length of the
genome. The contrast of these genome information per-
centages is illustrated in ﬁgure 4. To understand this ﬁg-
ure, it is instructive to examine the X-axis at a threshold
of 50% information content. Approximately 10% of the
genome had at least 50% information content for the M-
STRs, ∼80% of the genome had at least 50% information
content for the SNPs, and ∼90% of the genome had at
least 50% information content for the combination of
both M-STRs and SNPs. This ﬁgure illustrates the dra-
matic increase in the information content provided by the
high-density SNPs, in contrast to the little gain provided
by combining the M-STRs with the SNPs.
Subgroup Analyses
Pedigrees were stratiﬁed on the basis of pedigree av-
erage age at diagnosis (!66 years vs.66 years), number
of men affected (!5 vs. 5), HPC (yes vs. no), and pa-
ternal transmission of disease in a pedigree, in which
both a father and son have prostate cancer (yes vs. no),
as a surrogate for X linkage. Figure 5 presents the max-
imum LOD score for each subset, by chromosome and
by analysis using SNPs versus M-STRs. This ﬁgure
shows that, on average, the LOD scores for the SNPs
are higher than those for the M-STRs, and LOD scores
13 occurred on chromosomes 6, 12, 20, and X for the
SNPs but not for the M-STRs. However, this ﬁgure does
not show where on the chromosomes the differences
occurred. To illustrate some of the differences, we pre-
sent the LOD-score curves for the subset with an age at
diagnosis of 66 years, for chromosomes 6, 8, 12, 16,
and 20 (ﬁg. 6). This ﬁgure illustrates that, for chro-
mosomes 6, 12, and 16, the differences in LOD scores
occurred only at the extreme ends of the chromosomes,
whereas, for chromosomes 8 and 20, the larger LOD
scores for the SNPs appeared more consistent through-
out longer stretches of the chromosomes. These patterns
were similar in other subsets (data not shown). On the
other hand, for some subsets, there were some chro-
mosomes for which the LOD scores were greater for the
M-STRs than for the SNPs—in particular, chromosomes
10 and 20.
Discussion
Until recently, M-STRs have been the primary type of
markers used for linkage analyses. They are abundant
and equally dispersed throughout the genome, and, be-
cause they are highly polymorphic, they are highly in-
formative. Because of these marker characteristics, their
use over the years has been extremely valuable. The in-
creased availability of SNPs now provides an opportu-
nity for alternative methodologic approaches. SNPs are
more abundant than microsatellites and are also dis-
persed equally throughout the genome, but they are less
informative than microsatellites, because they are only
diallelic. Thus, a considerably larger number of SNP
markers are required to achieve an information content
similar to that of microsatellites. The advent of several
high through-put genotyping platforms, including that
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Figure 4 Percentage of genome exceeding different levels of genetic information for SNP markers (dotted line), M-STR markers (dashed
line), and the combination of SNPs and M-STRs (solid line).
by Affymetrix, make it now feasible to use SNPs for
linkage analysis. Although there is a great deal of ex-
perience in the use of microsatellite markers—in terms
of both laboratory and statistical methods for linkage
analysis—there is very little experience with large-scale
SNP mapping projects. In this study, we compare these
two analytical approaches to linkage.
Overall, the quality of the SNP genotypes was ex-
cellent. We achieved a mean call rate per SNP of 95%,
with an estimated error rate of 0.05%–0.08%. Al-
though technology has advanced considerably over the
years, we were able to complete the analytical phase of
the project in a matter of months for the SNP-based
genotyping, compared with years for the M-STR–based
genotyping. Although the Affymetrix array contains
10,043 SNPs, only 5,656 were utilized in the ﬁnal analy-
sis (table 2). The number of usable markers will cer-
tainly increase over time, because we used an early-
access array and because our conservative approach
preferred exclusion of SNPs. In addition to the labo-
ratory analytical issues that need to be addressed, soft-
ware challenges remain, including the need for pro-
grams that can handle large data sets for parametric
linkage analyses, as well as the presence of LD.
Our results suggest that the presence of LD among
SNPs can lead to inﬂated LOD scores, and this seems to
be an artifact due to the assumption of linkage equilib-
rium that is required by the current genetic-linkage soft-
ware. We excluded SNPs with high LD, deﬁned as
. Although this criterion likely captures the′FDF 1 0.7
most extreme impact of LD on the linkage results, it is
possible for any remaining LD, either pairwise values
with or higher-order disequilibria, to still in-′FDF  0.7
ﬂuence our linkage results. With this caveat, we found,
using SNPs, a number of new LOD-score peaks with
values of at least 2.0 that were not found using the M-
STR data. Chromosome 8, with a maximum LOD score
of 2.2, supports recent linkage evidence for chromosome
8 (Xu et al. 2001), along with the candidate gene MSR,
which maps to this region (Xu et al. 2002). Chromosome
2, with a maximum LOD score of 2.1, is consistent with
three other reports of suggestive linkage (LOD scores
between 1 and 3) to this chromosome (Suarez et al. 2000;
Edwards et al. 2003; Xu et al. 2003). Chromosome 6,
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Figure 6 Example LOD-score plots for the subset of pedigrees with an average age at diagnosis of 166 years, to compare the LOD scores
for SNPs versus M-STRs.
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with a maximum LOD score of 4.2, is consistent with
the suggestive linkage (LOD scores between 1 and 3)
reported by three different groups (Edwards et al. 2003;
Janer et al. 2003; Xu et al. 2003). Chromosome 12, with
a maximum LOD score of 3.9, is consistent with two
reports of LOD scores between 1 and 2 for this chro-
mosome (Suarez et al. 2000; Hsieh et al. 2001). For chro-
mosomes 2, 6, and 12, the meaning of the maximum
LOD scores occurring at the extreme ends of these chro-
mosomes is not entirely clear. Although it is possible for
susceptibility genes to exist at the extreme ends, there
may be unknown errors in the genetic map. For chro-
mosome 6, there is a series of LOD-score peaks 11.0 at
∼80 cM. It may be that geneticmap errors have “pushed”
a high LOD score to the extreme end of chromosome 6,
because the multipoint analyses are not robust to map
errors (Risch and Giuffra 1992). Chromosomes 2 and
12 may be subject to this same problem, although the
strength of evidence is weaker for these chromosomes.
Our ﬁnding of new linkage peaks by use of SNPs is
consistent with two recent studies that compared SNP
versus M-STR linkage results, for bipolar disorder (Mid-
dleton et al. 2004) and for rheumatoid arthritis (John et
al. 2004). The study byMiddleton et al. (2004)was based
on 148 genotyped subjects from 25 families, with an
average of 5.9 genotyped subjects per family. In contrast,
we genotyped 467 affected men from 167 families—an
average of 2.8 genotyped subjects per family. Hence, our
families each had a lower genetic-linkage information
content, so our evaluation of the differences between SNP
and M-STR linkage results is based on different types of
families than those used by Middleton et al. (2004). This
was reﬂected in our average information content of 61%
for the SNPs, versus an average of 84% reported by
Middleton et al. (2004). A strength of our study was the
larger number of families, allowing more critical evalu-
ation of the impact of LD on the resulting LOD scores.
The study by John et al. (2004) was based on 157 fam-
ilies, of which 37% had DNA available from one or both
parents, with an average information content of 75%.
Furthermore, John et al. (2004) reported that some SNPs
in high LD slightly increased NPL scores, whereas other
high-LD SNPs led to a modest reduction in NPL scores,
and they concluded that the cause of change in NPL
scores because of exclusion of high-LD SNPs could be a
result of either the software not accounting for LD or a
loss of genetic information. Their deﬁnition of high LD
differed from ours; we used to deﬁne high LD,′FDF 1 0.7
in contrast to , used by John et al. (2004). With2r  0.4
our deﬁnition of high LD, our results suggest that it is
likely that high LD inﬂuences LOD scores, because only
minor differences in the information content occurred
when we excluded the high-LD SNPs. Another difference
between our study and that of John et al. (2004) is that
we used the Kong andCox (1997) LOD score, in contrast
to theNPL score used by John et al. It is not clearwhether
this difference in choice of statistic can lead to different
conclusions regarding the impact of LD on linkage
statistics.
In conclusion, for our pedigrees, the SNP markers
provided a higher information content than the M-STR
markers, with averages of 61% versus 41%, respec-
tively. These averages are remarkably consistent with
recent simulations that conﬁrm that a dense map of
SNPs provides substantially greater information content
than the traditional map ofM-STRs spaced at 1 marker/
∼10 cM when parents are not genotyped (Evans and
Cardon 2004). These simulation studies also showed
that more-sparse marker maps are just as informative
if parental genotypes are available. Furthermore, the
SNPs identiﬁed more linkage peaks with more-narrow
widths than did M-STR markers; some linkage signals
would have gone undetected by our 10-cM genome scan
with M-STRs. Further follow-up of the linkage signals
in our families, with selection of additional SNPs and
evaluation of candidate genes, is warranted. Although
the presence of LD among the SNPs complicated the
linkage analyses, we were able to at least partially ad-
dress this by removing those SNPs that were in high LD
with other SNPs. Another limitation of using SNPs in
our families was the inability to detect Mendelian er-
rors, although we circumvented this by using theMerlin
software that statistically identiﬁes and eliminates likely
genotyping errors. Perhaps one of the most difﬁcult is-
sues, at least in the study of our small families, was the
inability to accurately validate genetic maps. As more
information becomes available from other linkage stud-
ies using SNPs, this concern may diminish. One can
envision pooling a large number of studies in order to
validate SNP genetic maps.
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